Central Bank & Trust’s Novo Nordisk NVO Stock Holding History

Central Bank & Trust’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$707K	Sell	14,753 -725	-5%	-$31.1K	0.1%	125
2026 Q1	$569K	Buy	15,478 +2,225	+17%	+$105K	0.09%	132
2025 Q4	$674K	Sell	13,253 -1,386	-9%	-$70.9K	0.1%	126
2025 Q3	$812K	Sell	14,639 -2,119	-13%	-$124K	0.13%	121
2025 Q2	$1.16M	Sell	16,758 -3,997	-19%	-$272K	0.19%	98
2025 Q1	$1.44M	Sell	20,755 -6,332	-23%	-$523K	0.24%	86
2024 Q4	$2.33M	Sell	27,087 -4,591	-14%	-$496K	0.35%	65
2024 Q3	$3.77M	Buy	31,678 +31,183	+6,300%	+$4.16M	0.52%	53
2024 Q2	$70.7K	Buy	+495	New	+$65.6K	0.01%	238

Other funds holding NVO

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return

OFA

Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return

PFS

Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

VFM

Viking Fund Management Minot, North Dakota $1.12B AUM 44.65% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Central Bank & Trust's NVO Position: Q2 2026 in Review

Central Bank & Trust reduced its Novo Nordisk (NVO) stake by 4.7% in Q2 2026, selling an estimated $31.1K and leaving 14,753 shares worth $707K. The position accounts for 0.1% of the portfolio, ranked #125.

Central Bank & Trust first reported a position in NVO in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.77M in Q3 2024. 247 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Central Bank & Trust held 14,753 shares of Novo Nordisk worth $707K as of Q2 2026.
Central Bank & Trust sold 725 Novo Nordisk shares in Q2 2026, an estimated $31.1K.
Novo Nordisk made up 0.1% of Central Bank & Trust's portfolio in Q2 2026, its #125 holding.
Central Bank & Trust first reported a position in Novo Nordisk in Q2 2024 and has held it in 9 quarters since.
Central Bank & Trust's Novo Nordisk position peaked at $3.77M in Q3 2024.
247 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Central Bank & Trust's 13F filing for Q2 2026, filed 17 Jul 2026.